Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 1995Antimicrobial Agents and ChemotherapyOpen Access

The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase

View Full Paper
Ask AI
Bookmark
Share

Authors

CÅC. ÅhgrenKBK BackroFBF. WILLIAM BELL

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Åhgren et al. (1995) studied this question.

synapsesocial.com/papers/6aad04287fbce0ecd0dc06dfhttps://doi.org/10.1128/aac.39.6.1329
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 12-Pyridinone derivatives: a new class of nonnucleoside, HIV-1-specific reverse transcriptase inhibitors1991 · 107 citations
  2. 2Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones1991 · 208 citations
  3. 3Characterization of HIV Reverse Transcriptases with Tyr181→Cys and Leu100→lle Mutations1993 · 16 citations
  4. 4Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors1991 · 363 citations
  5. 5Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase and human DNA polymerases alpha, beta, and gamma by the 5'-triphosphates of carbovir, 3'-azido-3'-deoxythymidine, 2',3'-dideoxyguanosine and 3'-deoxythymidine. A novel RNA template for the evaluation of antiretroviral drugs1991 · 133 citations